Skip to main content
. 2020 Jul 10;11(1):77–98. doi: 10.1016/j.jcmgh.2020.07.003

Figure 4.

Figure 4

Muc2–/–FMT increases susceptibility to DSS-induced colitis in Muc2+/+littermates. (A) Antibiotic treated Muc2+/+ receiving Muc2–/– FMT showed increased mortality to DSS induced colitis and the surviving animals did not recover weight up to day 14. (B) Muc2–/– mice receiving Muc2+/+ FMT showed less severe illness and no mortality in response to DSS induced colitis. (C) Muc2+/+ mice receiving Muc2–/– FMT showed an increased in DAI compared with those who received their own. (D) On day 14, Muc2+/+ receiving Muc2–/– FMT showed increased intestinal permeability as compared with Muc2+/+ receiving their own microbiota. (E) Survival and body weight change of Muc2+/+ and Muc2–/– bone marrow (BM) chimeras challenged with DSS. n = 4–6, ∗P < .05, ∗∗P < .01, BW, body weight.